Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger Eidtmann; Alain Monnier; Patrick Neven; Gunter von Minckwitz; Joel C. Miller; Nora L. Schenk; Robert E. Coleman

doi:10.1002/cncr.23259

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

Cancer ◽

10.1002/cncr.23259 ◽

2008 ◽

Vol 112 (5) ◽

pp. 1001-1010 ◽

Cited By ~ 157

Author(s):

Nigel J. Bundred ◽

Ian D. Campbell ◽

Neville Davidson ◽

Richard H. DeBoer ◽

Holger Eidtmann ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Effective Inhibition

Download Full-text

2008 POSTER The E-ZO-FAST trial: Zoledronic acid (ZA) effectively inhibits aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant Letrozole (Let)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70770-x ◽

2007 ◽

Vol 5 (4) ◽

pp. 186-187 ◽

Cited By ~ 21

Author(s):

N. Schenk ◽

A. Lombart ◽

A. Frassoladti ◽

P. Neven ◽

G. Jerusalem ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.

10.1158/0008-5472.sabcs-44 ◽

2009 ◽

Cited By ~ 21

Author(s):

H Eidtmann ◽

NJ Bundred ◽

R DeBoer ◽

A Llombart ◽

N Davidson ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST Study 5-Year Final Follow-Up.

10.1158/0008-5472.sabcs-09-4083 ◽

2009 ◽

Cited By ~ 11

Author(s):

A. Brufsky ◽

G. Harker ◽

J. Beck ◽

R. Carroll ◽

L. Jin ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Zoledronic acid (ZA) prevents aromatase inhibitor (Al)-associated bone loss in postmenopausal women with early breast cancer -36-month follow-up of the Z-FAST study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70810-3 ◽

2008 ◽

Vol 6 (7) ◽

pp. 197 ◽

Cited By ~ 1

Author(s):

A. Brufskv ◽

L. Bosserman ◽

R. Caradonna ◽

B. Haley ◽

M. Jones ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

The Breast ◽

10.1016/s0960-9776(07)70213-8 ◽

2007 ◽

Vol 16 ◽

pp. S57 ◽

Cited By ~ 1

Author(s):

A. Brufsky ◽

N. Bundred ◽

R. Coleman ◽

R. Lambert-Falls ◽

R. Mena ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Integrated Analysis

Download Full-text

P154 Twenty-four month follow-up of the effect of zoledronic acid (ZA) on aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

The Breast ◽

10.1016/s0960-9776(07)70214-x ◽

2007 ◽

Vol 16 ◽

pp. S57 ◽

Cited By ~ 3

Author(s):

A. Brufsky ◽

K. Lund ◽

S. Papish ◽

P. Cobb ◽

P. Eisenberg ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Abstract P5-11-01: The Effect of Zoledronic Acid on Aromatase Inhibitor Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The ZO-FAST Study 5-Year Final Follow-Up

10.1158/0008-5472.sabcs10-p5-11-01 ◽

2010 ◽

Cited By ~ 10

Author(s):

R DeBoer ◽

N Bundred ◽

H Eidtmann ◽

A Llombert ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

Clinical Breast Cancer ◽

10.3816/cbc.2009.n.015 ◽

2009 ◽

Vol 9 (2) ◽

pp. 77-85 ◽

Cited By ~ 143

Author(s):

Adam M. Brufsky ◽

Linda D. Bosserman ◽

Richard R. Caradonna ◽

Barbara B. Haley ◽

C. Michael Jones ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole

The Oncologist ◽

10.1634/theoncologist.2007-0206 ◽

2008 ◽

Vol 13 (5) ◽

pp. 503-514 ◽

Cited By ~ 123

Author(s):

Adam Brufsky ◽

Nigel Bundred ◽

Robert Coleman ◽

Rosemary Lambert‐Falls ◽

Raul Mena ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Integrated Analysis

Download Full-text

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.08.002 ◽

2012 ◽

Vol 12 (1) ◽

pp. 40-48 ◽

Cited By ~ 84

Author(s):

Antonio Llombart ◽

Antonio Frassoldati ◽

Outi Paija ◽

Harm Peter Sleeboom ◽

Guy Jerusalem ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text